Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 1998 Dec 7;12(5):263–267. doi: 10.1002/(SICI)1098-2825(1998)12:5<263::AID-JCLA2>3.0.CO;2-7

An enzyme‐linked immunosorbent assay and reference ranges for bisphosphoglycerate mutase in human erythrocytes

Takayuki Takubo 1,, Izumi Tsuda 1, Noriyuki Tatsumi 1, Kenji Kasuya 2, Yoshiyuki Taniguchi 2, Tsuyoshi Fujita 2, Kohji Uchida 2, Yuhsi Matsuo 2, Taizo Hayashi 3
PMCID: PMC6807899  PMID: 9773955

Abstract

We established an enzyme‐linked immunosorbent assay (ELISA) system for the determination of human bisphosphoglycerate mutase (BPGM) protein content in human erythrocytes using a polyclonal anti‐BPGM antibody, we determined reference ranges for BPGM protein content, synthase activity, and specific activity in human erythrocytes. We produced a recombinant human BPGM (rBPGM) by gene manipulation using E. coli and then obtained the polyclonal antibody by immunizing rabbits with purified rBPGM. The reproducibility of the ELISA was in an acceptable range with a coefficient of variation under 1.5%. The ELISA was reliable in the range of 0.1 to 10 ng/mL. The polyclonal anti‐rBPGM antibody did not show any cross‐reaction with recombinant human B type phosphoglycerate mutase, which is highly homologous to rBPGM. The ELISA was found to be practical for the determination of BPGM protein content in human erythrocytes. The mean BPGM protein content was 56.3 ± 9.7 μg/mL in whole blood (mean ± SD, n = 50). The ELISA can be used to examine various hematologic disorders with abnormal red cell size and cell counts, and to detect BPGM enzymopathy in human erythrocytes. J. Clin. Lab. Anal. 12:263–267, 1998. © 1998 Wiley‐Liss, Inc.

Keywords: bisphosphoglycerate mutase, immunoassay, polyclonal antibody, reference range, enzymopathy

References

  • 1. Travis SF, Martinez J, Gravin J Jr, Atwater J, Gillmer P: Study of a kindred with partial deficiency of red cell 2,3‐diphosphoglycerate mutase (2,3‐DPGM) and compensated hemolysis. Blood 51: 1107–1116, 1978. [PubMed] [Google Scholar]
  • 2. Rosa R, Prehu M‐O, Beuzard Y, Rosa J: The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes. J Clin Invest 62: 907–915, 1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Calvin MC, Blouquit Y, Garel MC, Prehu MO, Cohen‐Solal M, Rosa J, Rosa R: Human bisphosphoglycerate mutase expressed in E coli: Purification, characterization, and structure studies. Biochimie 72: 337–343, 1990. [DOI] [PubMed] [Google Scholar]
  • 4. Uchida K, Kondoh K, Matsuo Y: Recombinant M‐, B‐, and MB‐type isozymes of human phosphoglyceric acid mutase: Their large‐scale production and preparation of polyclonal antibodies specific to M‐ and B‐type isozymes. Clin Chim Acta 237: 43–58, 1995. [DOI] [PubMed] [Google Scholar]
  • 5. Uchida K, Mori K, Hayashi T, Matsuo Y: Preparation of recombinant human bisphosphoglyceric acid mutase and its application. Jpn J Clin Chem 24 (Suppl 3): 75c, 1995. [Google Scholar]
  • 6. Schröter W: Kongenitale nichtspharocytare hamolytische anamie bei 2,3‐diphosphoglyceratmutase‐mangel der erythrocyten im fruhen sauglingsalter. Klin Wochenschr 43: 1147–1153, 1965. [DOI] [PubMed] [Google Scholar]
  • 7. Rose ZB, Liebowitz J: 2,3‐diphosphoglycerate phosphatase from human erythrocytes: General properties and activation by anions. J Biol Chem 245: 3232–3241, 1970. [PubMed] [Google Scholar]
  • 8. Rose ZB: Effects of salts and pH on the rate of erythrocyte diphosphoglycerate mutase. Arch Biochem Biophys 158: 903–909, 1973. [DOI] [PubMed] [Google Scholar]
  • 9. Rapoport S, Luebering J: The formation of 2,3‐diphosphoglycerate in rabbit erythocytes: The existence of a diphosphoglycerate mutase. J Biol Chem 183: 507–516, 1950. [Google Scholar]
  • 10. Rose ZB: The purification and properties of diphosphoglycerate mutase from human erythrocytes. J Biol Chem 243: 4810–4820, 1968. [PubMed] [Google Scholar]
  • 11. Rosa R, Gaillardon J, Rosa J: Diphosphoglycerate mutase and 2,3‐diphosphoglycerate phosphatase activities of red cells: Comparative electrophoretic study. Biochem Biophys Res Commun 51: 536–542, 1973. [DOI] [PubMed] [Google Scholar]
  • 12. Rosa R, Prehu M‐O, Albrect‐Ellmer K, Calvin MC: Partial characterization of the inactive mutant form of human red cell bisphosphoglyceromutase and comparison with alkylated form. Biochem Biophys Acta 742: 243–249, 1983. [DOI] [PubMed] [Google Scholar]
  • 13. Lamarchandel V, Joulin V, Valentin C, Rosa R, Galacteros F, Rosa J, Cohen‐Solal M: Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency. Blood 80: 2643–2649, 1992. [PubMed] [Google Scholar]
  • 14. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–268, 1951. [PubMed] [Google Scholar]
  • 15. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350–4354, 1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Uchida K: Recombination and amplification of multiple portions of genomic DNA by a modified polymerase chain reaction. Anal Biochem 202: 159–161, 1992. [DOI] [PubMed] [Google Scholar]
  • 17. Uchida K: cDNA encoding type B subunit of rat phosphoglycerate mutase: Its isolation and nucleotide sequence. Arch Biochem Biophys 288: 558–561, 1991. [DOI] [PubMed] [Google Scholar]
  • 18. Takubo T, Tatsumi N, Tsuda I, et al.: Reference values for bisphosphoglycerate mutase protein content and specific activity in human erythrocytes. Acta Haematol 99: 234–235, 1998. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES